Advertisement

Geriatrics

Home Geriatrics
Comorbidity burden is strongly and independently associated with pathological upgrading/up staging in men with clinically low-risk prostate cancer

Comorbidity Tied to Prostate Cancer Upgrading, Up Staging

Findings among men with clinically low-risk prostate cancer
Alcohol

Stomach CA Risk Up With Alcohol, Processed Meat Consumption

Excess weight also seems to increase chances of disease, and risk increases as three factors increase
Declines in prostate cancer mortality seem to parallel declines in cigarette smoking

Decrease in Prostate CA Mortality Parallels Drop in Smoking

Findings based on data for men aged 35 years and older from California, Kentucky, Maryland, Utah
For patients with hypertriglyceridemia

LDL Reduction in Hypertriglyceridemia Varies Per Statin

Greater LDL-C reductions for rosuvastatin 10-40 mg vs equal, double doses of atorvastatin, simvastatin
A recently approved

AACR: Cologuard Can Detect CRC in Previously Unscreened Patients

Cologuard may help spot tumors, but colonoscopy still preferred option
Metformin is associated with reduced cardiovascular mortality compared with sulfonylureas

Lower CVD Mortality for Metformin Versus Sulfonylureas

Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
The prevalence of urinary tract malignancy is low among postmenopausal women evaluated for asymptomatic microscopic hematuria

Suboptimal Guideline Adherence for Hematuria After Menopause

Low rate of urinary tract malignancy for women evaluated for asymptomatic microscopic hematuria
A case of postoperative acute gouty arthritis following laparoscopic cholecystectomy with umbilical hernioplasty

Post-Op Gouty Arthritis Described in Patient Taking Thiazide

Case of postoperative acute gouty arthritis documented, secondary to hydrochlorothiazide use
Network meta-analysis

Network Meta-Analysis Recommends Prostaglandins for Glaucoma

Highest-ranking class for reducing intraocular pressure was prostaglandins for 1999, 2004, 2009
For patients with post-myocardial infarction heart failure

Mineralocorticoid Receptor Antagonists No Benefit Post MI

MRA in addition to standard therapy does not improve outcome in setting of post-MI heart failure